{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:34:16Z","timestamp":1792096456534,"version":"4.4.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK110023"],"award-info":[{"award-number":["R01 DK110023"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.kint.2023.12.021","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T16:22:00Z","timestamp":1708791720000},"page":"960-970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome\/complement-mediated thrombotic microangiopathy"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7853-0560","authenticated-orcid":false,"given":"Michael","family":"Che","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Y.M.","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme N.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Khaled","family":"Shamseddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Avila-Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn S.","family":"Garland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2023.12.021_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.amjmed.2012.09.006","article-title":"Untying the knot of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome","volume":"126","author":"Tsai","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.kint.2023.12.021_bib2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/asheducation-2015.1.644","article-title":"Syndromes of thrombotic microangiopathy associated with pregnancy","volume":"2015","author":"George","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.kint.2023.12.021_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.preghy.2018.02.007","article-title":"Thrombotic microangiopathies of pregnancy: differential diagnosis","volume":"12","author":"Gupta","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.kint.2023.12.021_bib4","article-title":"A\u00a0review of roles of uterine artery Doppler in pregnancy complications","volume":"9","author":"Tian","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.kint.2023.12.021_bib5","first-page":"407","article-title":"The Extended use of eculizumab in pregnancy and complement activation(-)associated diseases affecting maternal, fetal and neonatal kidneys-the future is now?","volume":"8","author":"Stefanovic","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.kint.2023.12.021_bib6","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJMoa1502950","article-title":"Eculizumab in pregnant patients with paroxysmal nocturnal hemoglobinuria","volume":"373","author":"Kelly","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.12.021_bib7","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2023.12.021_bib8","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","article-title":"Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial","volume":"393","author":"Duhig","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2023.12.021_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ajkd.2018.11.012","article-title":"An ex\u00a0vivo test of complement activation on endothelium for individualized eculizumab therapy in hemolytic uremic syndrome","volume":"74","author":"Galbusera","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2023.12.021_bib10","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.kint.2023.12.021_bib11","article-title":"Complement factor I variants in complement-mediated renal diseases","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.kint.2023.12.021_bib12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jogc.2022.03.002","article-title":"Guideline no. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management","volume":"44","author":"Magee","year":"2022","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.kint.2023.12.021_bib13","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1161\/HYPERTENSIONAHA.121.17311","article-title":"Differentiating hemolysis, elevated liver enzymes, and low platelet count syndrome and atypical hemolytic uremic syndrome in the postpartum period","volume":"78","author":"Burwick","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2023.12.021_bib14","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood.2020005221","article-title":"Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group","volume":"136","author":"Fakhouri","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.kint.2023.12.021_bib15","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"Bendapudi","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.kint.2023.12.021_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/microorganisms6040111","article-title":"Shiga toxin-producing Escherichia coli infections during pregnancy","volume":"6","author":"Sacerdoti","year":"2018","journal-title":"Microorganisms"},{"key":"10.1016\/j.kint.2023.12.021_bib17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.2004100861","article-title":"Hemolytic uremic syndrome","volume":"16","author":"Noris","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.12.021_bib18","first-page":"3034","article-title":"The syndromes of thrombotic microangiopathy: a critical appraisal on complement dysregulation","volume":"10","author":"Timmermans","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.kint.2023.12.021_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100084","article-title":"Etiology and outcomes: thrombotic microangiopathies in pregnancy","volume":"7","author":"Scully","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.kint.2023.12.021_bib20","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome","volume":"21","author":"Dragon-Durey","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.12.021_bib21","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.ekir.2021.01.034","article-title":"Functional and genetic landscape of complement dysregulation along the spectrum of thrombotic microangiopathy and its potential implications on clinical outcomes","volume":"6","author":"Timmermans","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2023.12.021_bib22","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.kint.2023.12.021_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejogrb.2012.09.026","article-title":"Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review","volume":"166","author":"Abildgaard","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.kint.2023.12.021_bib24","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2215\/CJN.15121219","article-title":"Updates in diagnosis and management of preeclampsia in women with CKD","volume":"15","author":"Wiles","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.12.021_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.preghy.2017.03.003","article-title":"Clinical and laboratory markers in the recovery from severe preeclampsia","volume":"8","author":"Rotem","year":"2017","journal-title":"Pregnancy Hypertens"},{"issue":"suppl","key":"10.1016\/j.kint.2023.12.021_bib26","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.ajog.2015.08.042","article-title":"Why is placentation abnormal in preeclampsia?","volume":"213","author":"Fisher","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.kint.2023.12.021_bib27","first-page":"467","article-title":"Pre-eclampsia: pathophysiology, diagnosis, and management","volume":"7","author":"Uzan","year":"2011","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.kint.2023.12.021_bib28","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/jhh.2017.61","article-title":"Placental growth factor and pre-eclampsia","volume":"31","author":"Chau","year":"2017","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.kint.2023.12.021_bib29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2023.12.021_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2147\/IJWH.S368454","article-title":"Perspectives on the use of placental growth factor (PlGF) in the prediction and diagnosis of pre-eclampsia: recent insights and future steps","volume":"15","author":"Creswell","year":"2023","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.kint.2023.12.021_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/uog.17494","article-title":"Placental histopathology associated with pre-eclampsia: systematic review and meta-analysis","volume":"50","author":"Falco","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.kint.2023.12.021_bib32","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2023.12.021_bib33","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2023.12.021_bib34","series-title":"PLGF-based testing to help diagnose suspected preterm pre-eclampsia","year":"2022"},{"key":"10.1016\/j.kint.2023.12.021_bib35","author":"Park"},{"key":"10.1016\/j.kint.2023.12.021_bib36","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.kint.2015.10.012","article-title":"Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease","volume":"89","author":"Bramham","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.12.021_bib37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.preghy.2021.02.010","article-title":"Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease","volume":"24","author":"Wiles","year":"2021","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.kint.2023.12.021_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1143543","article-title":"Potential biomarkers for late-onset and term preeclampsia: a scoping review","volume":"14","author":"Han","year":"2023","journal-title":"Front Physiol"},{"key":"10.1016\/j.kint.2023.12.021_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2023.12.021_bib40","series-title":"GeneReviews\u00ae. University of Washington","article-title":"Genetic atypical hemolytic-uremic syndrome","author":"Noris","year":"1993"},{"key":"10.1016\/j.kint.2023.12.021_bib41","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2215\/CJN.00280117","article-title":"Hemolytic uremic syndrome in pregnancy and postpartum","volume":"12","author":"Bruel","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.12.021_bib42","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/bjh.16626","article-title":"The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives","volume":"190","author":"Timmermans","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.kint.2023.12.021_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-010-1556-4","article-title":"aHUS caused by complement dysregulation: new therapies on the horizon","volume":"26","author":"Waters","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2023.12.021_bib44","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1182\/blood.2020009280","article-title":"Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study","volume":"137","author":"Fakhouri","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.kint.2023.12.021_bib45","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1053\/j.ajkd.2015.02.326","article-title":"Soluble c5b-9 as a biomarker for complement activation in atypical hemolytic uremic syndrome","volume":"65","author":"Bu","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2023.12.021_bib46","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.mayocp.2018.07.008","article-title":"Diagnostic utility of complement serology for atypical hemolytic uremic syndrome","volume":"93","author":"Sridharan","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.kint.2023.12.021_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13202","article-title":"Normal range of complement components during pregnancy: a prospective study","volume":"83","author":"He","year":"2020","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.kint.2023.12.021_bib48","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ekir.2019.03.012","article-title":"Diagnostic indicators of superimposed preeclampsia in women with CKD","volume":"4","author":"Wiles","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2023.12.021_bib49","first-page":"698","article-title":"Enhanced anaphylatoxin and terminal C5b-9 complement complex formation in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"76","author":"Haeger","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.kint.2023.12.021_bib50","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/HYPERTENSIONAHA.113.01420","article-title":"Urinary excretion of C5b-9 in severe preeclampsia: tipping the balance of complement activation in pregnancy","volume":"62","author":"Burwick","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2023.12.021_bib51","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2215\/CJN.05830519","article-title":"Complement activation and thrombotic microangiopathies","volume":"14","author":"Palomo","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.12.021_bib52","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/ndt\/gfz025","article-title":"Post-partum acute kidney injury: sorting placental and non-placental thrombotic microangiopathies using the trajectory of biomarkers","volume":"35","author":"Meibody","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.12.021_bib53","article-title":"Deposition of the membrane attack complex in healthy and diseased human kidneys","volume":"11","author":"Koopman","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2023.12.021_bib54","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.kint.2019.05.008","article-title":"Eculizumab deposits in vessel walls in thrombotic microangiopathy","volume":"96","author":"Cassol","year":"2019","journal-title":"Kidney Int"},{"issue":"suppl 11","key":"10.1016\/j.kint.2023.12.021_bib55","first-page":"2","article-title":"Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis","volume":"14","author":"Laurence","year":"2016","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.kint.2023.12.021_bib56","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1681\/ASN.2018020184","article-title":"C5b9 formation on endothelial cells reflects complement defects among patients with renal thrombotic microangiopathy and severe hypertension","volume":"29","author":"Timmermans","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.12.021_bib57","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00467-014-2817-4","article-title":"An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome","volume":"29","author":"Johnson","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2023.12.021_bib58","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.kint.2020.01.035","article-title":"The long-acting C5 inhibitor, ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment","volume":"97","author":"Rondeau","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.12.021_bib59","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.12.021_bib60","first-page":"127","article-title":"Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment","volume":"30","author":"Walle","year":"2017","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2023.12.021_bib61","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.kint.2023.12.021_bib62","first-page":"17","article-title":"Eculizumab in pregnancy: a narrative overview","volume":"32","author":"Sarno","year":"2019","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2023.12.021_bib63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/blood-2015-06-642553","article-title":"Response: maternal and cord C5a in response to eculizumab","volume":"126","author":"Burwick","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.kint.2023.12.021_bib64","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/bcp.14565","article-title":"Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria","volume":"87","author":"Eliesen","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.kint.2023.12.021_bib65","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00467-018-4091-3","article-title":"Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use","volume":"34","author":"Wijnsma","year":"2019","journal-title":"Pediatr Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824001583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824001583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T03:34:16Z","timestamp":1716262456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253824001583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0085253824001583"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2023.12.021","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome\/complement-mediated thrombotic microangiopathy","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2023.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}